Alzheimer's drug trial pulled before it even started
Disease control
Terminated
This study aimed to test a drug called BAC in people with Alzheimer's disease or vascular dementia. The goal was to see if it could improve thinking and memory, and to check for side effects. However, the trial was withdrawn before any participants were enrolled, so no results ar…
Phase: PHASE2 • Sponsor: Botanicure Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC